Powder formulations containing tiotropium suitable for inhalation
US6881422B2 · kind B2 · utility
4Cited by
13References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 3, 2003 |
| Grant date | Apr 19, 2005 |
| Priority date | — |
| Expiry date | Apr 25, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/14
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A method of making a physically stable and homogenous powdered pharmaceutical composition comprising a tiotropium salt and a physiologically acceptable excipient, the method comprising:
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.